FRE — Fresenius SE & Co. KGaA Share News
0.000.00%
- €26.47bn
- €35.49bn
- €22.87bn
Dialysis giants DaVita and Fresenius Medical sued by employee benefits plan
Europe Research Roundup: Adecco Group, Barry Callebaut, EMS Chemie
Europe Research Roundup: Deliveroo, Endesa, Natwest Group
Brief: Fresenius Q1 Group EBIT At 654 Million Euros
Fresenius posts profit beat in first quarter, confirms outlook (updated)
Fresenius posts operating profit beat in first quarter
FMC shares climb to three month high as Q1 results exceed estimates
Europe Research Roundup: Airbus, Deutsche Telekom, L'Oreal
Quotes: Executives, trade and labour associations on Trump's reciprocal tariffs
Quotes: Executives, trade and labour associations on Trump's reciprocal tariffs
Brief: Fresenius Completes Divestment Of Vamed's International Project Business
Brief: Fresenius Kabi Reached A Global Settlement With Amgen Concerning Their Denosumab Biosimilars
Brief: Fresenius: Receives FDA Approval For Denosumab Biosimilars
Brief: Fresenius: Receives FDA Approval For Denosumab Biosimilars And Secures Global Settlement
Brief: FDA Approves Bomyntra & Conexxence, Biosimilars To Xgeva & Prolia
Brief: Fresenius SE CEO - We Continue To Believe In The Potential Of FMC And Its Shares - Call
Fresenius Medical Care's stock falls on Fresenius' stake sale
FMC falls as Fresenius sells part of stake
Brief: Fresenius Completes Sale Of Shares In FMC AG